INTEGRA LIFESCIENCES HOLDINGS CORPORATION Integra LifeSciences Holdings Corporation
Equities
IART
US4579852082
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.9 USD | +0.32% |
|
+9.15% | -29.05% |
Presenter SpeechRobert Marcus (Analysts)Good afternoon, everyone. I'm Robbie Marcus with the J...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.
Calendar
2024-07-23
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
30.9
USD
Average target price
34.2
USD
Spread / Average Target
+10.68%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -29.05% | 2.43B | |
| -7.16% | 178B | |
| -1.23% | 107B | |
| -4.86% | 67.04B | |
| -4.28% | 47.23B | |
| +10.32% | 44.62B | |
| +8.14% | 42.5B | |
| +15.53% | 25.22B | |
| -5.88% | 24.14B | |
| -5.38% | 23.69B |
- Stock Market
- Equities
- IART Stock
- News Integra LifeSciences Holdings Corporation
- Transcript : Integra LifeSciences Holdings Corporation Presents at 35th Annual JP Morgan Healthcare Conference, Jan-11-2017 02
